MM patients had higher levels of IL-17 than controls, possibly due to elevated levels of IL-6 in their bone marrow, which stimulates the generation of Th17 cells from CD4 naïve cells (as described in previous studies). Here, IL17A is linked to Miyoshi myopathy.